We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WU:NYSEWestern Union Company (The) Analysis

Data as of 2026-08-31 - not real-time

$7.08

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind The Western Union Company is bearish at $7.08, with short-term averages lagging the long-term ones. It has lost 18.2% over the past 30 days. RSI sits at 41.0, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $6.58 up to resistance at $7.52.
On valuation the read is undervalued — earnings multiple of 5.7 versus a 16.9 sector average, below the peer group. The 13.04% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 70.3%, a beta of 0.44 and a maximum drawdown of 38.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Western Union swung to a 26% EPS miss as the Americas retail money transfer business stalled and the delayed Intermex...Money transfer company Western Union NYSE:WU in Q2 CY2026, with sales flat year on year at $1.Business Wire17dWestern Union and Intermex Provide Update on Pending AcquisitionDENVER & MIAMI-- BUSINESS WIRE --The...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 8.67
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 5.7 versus sector average of 16.9
  • Trading below the 200-day average of 8.67

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 5.7 versus sector average of 16.9
  • Revenue contracting at -1.3%
  • Return on equity of 44.0%

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin9.80%
P/E Ratio5.7
ROE43.97%
ROA5.12%
Debt/Equity294.87
P/B Ratio2.4
Op. Cash Flow$609.7M
Free Cash Flow$357.3M
Industry P/E16.9

Technical Analysis

TrendBearish
RSI41.0
Support$6.58
Resistance$7.52
MA 20$7.23
MA 50$7.59
MA 200$8.67
MACDBullish
VolumeDecreasing
Fear & Greed Index94.32

Valuation

Fair Value$9.00
Target Price$7.09
Upside/Downside0.13%
GradeUndervalued
TypeValue
Dividend Yield13.04%

Risk Assessment

Beta0.44
Volatility70.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.